BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 33857585)

  • 1. Anti-proliferative and apoptotic effect of gemini curcumin in p53-wild type and p53-mutant colorectal cancer cell lines.
    Ebrahimi M; Babaei E; Neri F; Feizi MAH
    Int J Pharm; 2021 May; 601():120592. PubMed ID: 33857585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herbal Melanin Inhibits Real-Time Cell Proliferation, Downregulates Anti-Apoptotic Proteins and Upregulates Pro-Apoptotic p53 Expression in MDA-MB-231 and HCT-116 Cancer Cell Lines.
    Rajabathar JR; Al-Lohedan H; Arokiyaraj S; Mohammed F; Al-Dhayan DM; Faqihi NA; Al-Saigh H
    Medicina (Kaunas); 2023 Nov; 59(12):. PubMed ID: 38138165
    [No Abstract]   [Full Text] [Related]  

  • 3. Curcumin induces apoptosis in human colorectal carcinoma (HCT-15) cells by regulating expression of Prp4 and p53.
    Shehzad A; Lee J; Huh TL; Lee YS
    Mol Cells; 2013 Jun; 35(6):526-32. PubMed ID: 23686430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin Conjugates of Non-steroidal Anti-Inflammatory Drugs: Synthesis, Structures, Anti-proliferative Assays, Computational Docking, and Inflammatory Response.
    Laali KK; Zwarycz AT; Beck N; Borosky GL; Nukaya M; Kennedy GD
    ChemistryOpen; 2020 Aug; 9(8):822-834. PubMed ID: 32802728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin Nicotinate Selectively Induces Cancer Cell Apoptosis and Cycle Arrest through a P53-Mediated Mechanism.
    He YC; He L; Khoshaba R; Lu FG; Cai C; Zhou FL; Liao DF; Cao D
    Molecules; 2019 Nov; 24(22):. PubMed ID: 31752145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective
    Laka K; Mapheto KBF; Mbita Z
    Toxicol Rep; 2021; 8():1265-1279. PubMed ID: 34195018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells.
    Khosravani F; Amiri F; Mahmoudi R; Morshedi D; Kobarfard F; Alipour M; Hosseini E; Bardania H
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2347-2357. PubMed ID: 37831114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Biological Evaluation and Action Mechanism Study of New Mitochondria-Targeted Curcumin Derivative as Potential Antitumor Drugs.
    Lu Z; Gao Z; Song H; Zhou Y; Yuan W; Wang X; Zhang L; Hong Y; Meng Y; Hu J; Zheng G; Chang C
    Chem Biodivers; 2023 Jul; 20(7):e202300086. PubMed ID: 37294554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional CaCO
    Hu S; Xia K; Huang X; Zhao Y; Zhang Q; Huang D; Xu W; Chen Z; Wang C; Zhang Z
    J Nanobiotechnology; 2023 Sep; 21(1):353. PubMed ID: 37773145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural agents inhibit colon cancer cell proliferation and alter microbial diversity in mice.
    Farhana L; Sarkar S; Nangia-Makker P; Yu Y; Khosla P; Levi E; Azmi A; Majumdar APN
    PLoS One; 2020; 15(3):e0229823. PubMed ID: 32196510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-proliferative and apoptotic effects of curcumin on feline mammary gland tumor cells
    Deveci Ozkan A; Guney Eskiler G; Turna O; Kazan N; Sozen Kucukkara E; Baykal A; Sonmez K
    Iran J Vet Res; 2021; 22(3):222-229. PubMed ID: 34777523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and fabrication of functionalized curdlan-curcumin delivery system to facilitate the therapeutic effects of curcumin on breast cancer.
    Ganie SA; Naik RA; Dar OA; Rather LJ; Assiri MA; Li Q
    Int J Biol Macromol; 2024 Apr; 267(Pt 1):131388. PubMed ID: 38608982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic anti-cancer effect of sodium pentaborate pentahydrate, curcumin and piperine on hepatocellular carcinoma cells.
    Omeroglu Ulu Z; Degirmenci NS; Bolat ZB; Sahin F
    Sci Rep; 2023 Sep; 13(1):14404. PubMed ID: 37658091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin attenuates diphenyl phosphate-induced apoptosis in GC-2spd(ts) cells through activated autophagy via the Nrf2/P53 pathway.
    Wei L; Li S; Ma Y; Ye S; Yuan Y; Zeng Y; Raza T; Xiao F
    Environ Toxicol; 2024 Apr; 39(4):2032-2042. PubMed ID: 38095090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the P53 tumor suppressor gene and the Mcl-2 oncogene expression by an active herbal component delivered through a smart thermo-pH-sensitive PLGA carrier to improve Osteosarcoma treatment.
    Akbari P; Taebpour M; Akhlaghi M; Hasan SH; Shahriyari S; Parsaeian M; Haghirosadat BF; Rahdar A; Pandey S
    Med Oncol; 2024 Jan; 41(3):68. PubMed ID: 38289404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic derivatives of natural cinnamic acids as potential anti-colorectal cancer agents.
    Falbo F; Gemma S; Koch A; Mazzotta S; Carullo G; Ramunno A; Butini S; Schneider-Stock R; Campiani G; Aiello F
    Chem Biol Drug Des; 2024 Jan; 103(1):e14415. PubMed ID: 38230797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NRF2 activation in BON‑1 neuroendocrine cancer cells reduces the cytotoxic effects of a novel Ruthenium(II)‑curcumin compound: A pilot study.
    Garufi A; Pettinari R; Monteonofrio L; Puliani G; Virdia I; Appetecchia M; Marchetti F; Cirone M; Soddu S; D'Orazi G
    Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin inhibits human cancer cell growth and migration through downregulation of SVCT2.
    Jang SY; Kim J; Hong E; Lee K; Na Y; Yeom CH; Park S
    Cell Biochem Funct; 2023 Aug; 41(6):696-703. PubMed ID: 37322603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis in human colorectal cancer cells by nanovesicles from fingerroot (Boesenbergia rotunda (L.) Mansf.).
    Wongkaewkhiaw S; Wongrakpanich A; Krobthong S; Saengsawang W; Chairoungdua A; Boonmuen N
    PLoS One; 2022; 17(4):e0266044. PubMed ID: 35377896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated Phosphorylation of p53, Autophagy and Stemness Attributes the Mutant p53 Harboring Colon Cancer Cells Impaired Sensitivity to Oxaliplatin.
    Therachiyil L; Haroon J; Sahir F; Siveen KS; Uddin S; Kulinski M; Buddenkotte J; Steinhoff M; Krishnankutty R
    Front Oncol; 2020; 10():1744. PubMed ID: 32984059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.